tiprankstipranks
Ironwood Pharmaceuticals (IRWD)
NASDAQ:IRWD
US Market
IRWD
Ironwood Pharma
RESEARCH TOOLSreports
Want to see IRWD full AI Analyst Report?

Ironwood Pharma (IRWD) Ratios

440 Followers

Ironwood Pharma Ratios

IRWD's free cash flow for Q1 2026 was $1.00. For the 2026 fiscal year, IRWD's free cash flow was decreased by $ and operating cash flow was $0.68. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.41 1.13 4.69 0.84 30.58
Quick Ratio
 1.41 1.13 4.69 0.84 30.53
Cash Ratio
 0.93 0.89 2.28 0.33 25.71
Solvency Ratio
 0.16 0.04 <0.01 -1.22 0.39
Operating Cash Flow Ratio
 0.47 0.52 2.67 0.66 10.73
Short-Term Operating Cash Flow Coverage
 0.55 0.63 0.00 0.92 0.00
Net Current Asset Value
$ -319.42M$ -384.56M$ -469.88M$ -584.08M$ 332.49M
Leverage Ratios
Debt-to-Assets Ratio
 1.37 1.51 1.71 1.52 0.38
Debt-to-Equity Ratio
 -2.75 -2.28 -1.99 -2.07 0.64
Debt-to-Capital Ratio
 1.57 1.78 2.01 1.94 0.39
Long-Term Debt-to-Capital Ratio
 2.29 3.13 2.07 3.28 0.38
Financial Leverage Ratio
 -2.00 -1.52 -1.16 -1.36 1.69
Debt Service Coverage Ratio
 0.57 0.25 1.01 0.52 24.23
Interest Coverage Ratio
 5.97 3.63 2.82 -43.71 32.95
Debt to Market Cap
 0.91 1.08 0.83 0.39 0.21
Interest Debt Per Share
 3.86 3.89 3.98 4.74 2.74
Net Debt to EBITDA
 1.83 3.65 5.23 3.16 -0.92
Profitability Margins
Gross Profit Margin
99.62%100.00%97.85%98.61%99.65%
EBIT Margin
56.33%34.70%27.24%44.23%63.33%
EBITDA Margin
56.84%35.34%27.81%44.59%63.67%
Operating Profit Margin
55.83%40.10%26.50%-213.54%60.97%
Pretax Profit Margin
47.43%23.65%18.55%-214.14%61.48%
Net Profit Margin
28.26%8.11%0.25%-226.37%42.64%
Continuous Operations Profit Margin
28.26%8.11%0.25%-233.00%42.64%
Net Income Per EBT
59.59%34.30%1.35%105.71%69.35%
EBT Per EBIT
84.95%58.96%70.01%100.28%100.83%
Return on Assets (ROA)
23.51%6.05%0.25%-212.76%15.91%
Return on Equity (ROE)
-38.88%-9.17%-0.29%289.42%26.83%
Return on Capital Employed (ROCE)
101.81%76.78%29.84%-484.91%23.29%
Return on Invested Capital (ROIC)
29.97%11.39%0.40%-237.75%16.10%
Return on Tangible Assets
23.61%6.08%0.25%-214.43%15.91%
Earnings Yield
15.95%4.39%0.12%-56.36%9.15%
Efficiency Ratios
Receivables Turnover
 3.42 6.34 4.29 3.43 3.56
Payables Turnover
 0.43 0.00 3.55 0.79 2.94
Inventory Turnover
 0.00 0.00 0.00 0.00 1.13
Fixed Asset Turnover
 29.97 23.23 22.64 24.36 20.22
Asset Turnover
 0.83 0.75 1.00 0.94 0.37
Working Capital Turnover Ratio
 5.65 3.38 6.98 1.24 0.61
Cash Conversion Cycle
 -746.21 57.61 -17.75 -358.41 300.07
Days of Sales Outstanding
 106.86 57.61 85.05 106.45 102.64
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 321.76
Days of Payables Outstanding
 853.07 0.00 102.80 464.86 124.33
Operating Cycle
 106.86 57.61 85.05 106.45 424.39
Cash Flow Ratios
Operating Cash Flow Per Share
 0.69 0.78 0.65 1.18 1.77
Free Cash Flow Per Share
 0.69 0.78 0.65 1.18 1.77
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 37.40K 3.74K 729.22 671.89 2.01K
Capital Expenditure Coverage Ratio
 37.40K 3.74K 729.22 671.89 2.01K
Operating Cash Flow Coverage Ratio
 0.19 0.21 0.17 0.26 0.66
Operating Cash Flow to Sales Ratio
 0.31 0.43 0.29 0.41 0.67
Free Cash Flow Yield
17.39%23.23%14.67%10.30%14.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.27 22.76 800.84 -1.77 10.93
Price-to-Sales (P/S) Ratio
 1.78 1.85 2.01 4.02 4.66
Price-to-Book (P/B) Ratio
 -2.95 -2.09 -2.34 -5.13 2.93
Price-to-Free Cash Flow (P/FCF) Ratio
 5.75 4.30 6.82 9.71 6.99
Price-to-Operating Cash Flow Ratio
 5.71 4.30 6.81 9.69 6.99
Price-to-Earnings Growth (PEG) Ratio
 <0.01 <0.01 -8.00 <0.01 -0.17
Price-to-Fair Value
 -2.95 -2.09 -2.34 -5.13 2.93
Enterprise Value Multiple
 4.97 8.88 12.44 12.17 6.40
Enterprise Value
 1.02B 929.01M 1.22B 2.40B 1.67B
EV to EBITDA
 4.97 8.88 12.44 12.17 6.40
EV to Sales
 2.83 3.14 3.46 5.42 4.07
EV to Free Cash Flow
 9.11 7.31 11.76 13.11 6.11
EV to Operating Cash Flow
 9.11 7.31 11.74 13.09 6.11
Tangible Book Value Per Share
 -1.34 -1.63 -1.91 -2.25 4.23
Shareholders’ Equity Per Share
 -1.33 -1.61 -1.89 -2.23 4.23
Tax and Other Ratios
Effective Tax Rate
 0.40 0.66 0.99 -0.09 0.31
Revenue Per Share
 2.21 1.83 2.21 2.85 2.66
Net Income Per Share
 0.63 0.15 <0.01 -6.45 1.13
Tax Burden
 0.60 0.34 0.01 1.06 0.69
Interest Burden
 0.84 0.68 0.68 -4.84 0.97
Research & Development to Revenue
 0.24 0.32 0.32 0.26 0.11
SG&A to Revenue
 0.19 0.28 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.06 0.06 0.08 0.07 0.07
Income Quality
 0.68 5.29 117.67 -0.18 1.56
Currency in USD